|
|
Volumn 41, Issue 9, 1998, Pages 1548-1551
|
|
Combination therapy with biologic agents in rheumatoid arthritis: Perils and promise
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
FOLIC ACID;
FOLINIC ACID;
HYDROXYCHLOROQUINE;
INTERLEUKIN 1BETA;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ALOPECIA;
COMBINATION CHEMOTHERAPY;
DRUG INDICATION;
EDITORIAL;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
LUNG TOXICITY;
MALIGNANT NEOPLASTIC DISEASE;
ORAL DRUG ADMINISTRATION;
PATIENT SELECTION;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
STOMATITIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
DRUG THERAPY, COMBINATION;
HUMANS;
METHOTREXATE;
RECOMBINANT FUSION PROTEINS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0031681188
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/1529-0131(199809)41:9<1548::AID-ART4>3.0.CO;2-I Document Type: Editorial |
|
Times cited : (21)
|
|
References (16)
|
